The systemic availability of meptazinol in man after oral and rectal doses
- PMID: 2744068
- DOI: 10.1007/BF00558160
The systemic availability of meptazinol in man after oral and rectal doses
Abstract
We have studied the pharmacokinetics of the centrally-acting analgesic meptazinol after oral and rectal administration to 15 healthy men. Each subject took a standard 200 mg tablet orally and Witepsol H12 suppositories containing 75, 100, and 150 mg of the drug in a cross-over design. Meptazinol plasma concentrations were measured by HPLC using fluorescence detection and the pharmacokinetics determined. The tmax values for the 100 mg and 150 mg suppositories (median = 0.5 h) were statistically significantly shorter than for the tablet (median = 1.13 h), suggesting that meptazinol was more rapidly absorbed via the rectal route. Despite substantial intersubject variation in Cmax the plasma concentrations after rectal dosage were higher than after oral administration. There was a statistically significant (p less than 0.001) improvement in systemic availability for each of the suppository doses (mean approximately 15.5% compared with the oral tablet (mean approximately 4.5%).
Similar articles
-
The disposition of meptazinol after single and multiple intravenous administration to pregnant and non-pregnant women.Eur J Clin Pharmacol. 1989;36(3):273-7. doi: 10.1007/BF00558159. Eur J Clin Pharmacol. 1989. PMID: 2744067
-
The clinical pharmacokinetics and metabolism of the analgesic meptazinol.Xenobiotica. 1988 Jan;18(1):105-12. doi: 10.3109/00498258809055141. Xenobiotica. 1988. PMID: 3354226
-
Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects.Am J Health Syst Pharm. 2000 Aug 15;57(16):1499-505. doi: 10.1093/ajhp/57.16.1499. Am J Health Syst Pharm. 2000. PMID: 10965395 Clinical Trial.
-
Clinical review of parenteral meptazinol.Postgrad Med J. 1983;59 Suppl 1:85-92. Postgrad Med J. 1983. PMID: 6340086 Review.
-
Basics: Hollow-type Suppositories.Int J Pharm Compd. 2022 Jul-Aug;26(4):302-307. Int J Pharm Compd. 2022. PMID: 35820136 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources